Drug Shortage Report for AIROMIR
Report ID | 128517 |
Drug Identification Number | 02232570 |
Brand name | AIROMIR |
Common or Proper name | AIROMIR |
Company Name | BAUSCH HEALTH, CANADA INC. |
Market Status | MARKETED |
Active Ingredient(s) | SALBUTAMOL |
Strength(s) | 100MCG |
Dosage form(s) | METERED-DOSE AEROSOL |
Route of administration | INHALATION INHALATION |
Packaging size | 200 Dose |
ATC code | R03AC |
ATC description | ADRENERGICS, INHALANTS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2020-11-16 |
Estimated end date | |
Actual end date | 2020-12-01 |
Shortage status | Resolved |
Updated date | 2020-12-02 |
Company comments | waiting QA |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2150 BOUL. ST-ELZEAR OUEST LAVAL, QUEBEC CANADA H7L 4A8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2020-12-02 | French | Compare |
v3 | 2020-12-02 | English | Compare |
v2 | 2020-11-18 | French | Compare |
v1 | 2020-11-18 | English | Compare |
Showing 1 to 4 of 4